Optum-Amedisys deal likely to trigger FTC scrutiny
Analysts expect the Federal Trade Commission to scrutinize the proposed $3.3 billion deal between UnitedHealth Group’s Optum and home health company Amedisys. On Monday, Amedisys announced it had accepted the…